Back to Search
TERRY BEVERS, M.D.
M.D.
Adult Medicine Physician
NPI: 1548365174IndividualAccepts Medicare
Specialties, Licenses & Credentials
Adult Medicine PhysicianPrimary
Family Medicine — Adult Medicine
Code: 207QA0505X
H4153(TX)
CMS Specialties
PrimaryFAMILY PRACTICE
Additional
PREVENTIVE MEDICINE
Education
UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Class of 1987
Research & Publications (19)
The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
PMID 17927929·J Natl Compr Canc Netw·2007
6-review
Raloxifene and the prevention of breast cancer.
PMID 17059385·Expert Opin Pharmacother·2006
4-observational
Breast cancer chemoprevention: current clinical practice and future direction.
PMID 11769967·Biomed Pharmacother·2001
6-review
Validity assessment of the Breast Cancer Risk Reduction Health Belief scale.
PMID 19637346·Cancer·2009
4-observational
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years.
PMID 17851762·Breast Cancer Res Treat·2008
8-other
Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the university of Texas M.D. Anderson Cancer Center experience.
PMID 18483331·Cancer Epidemiol Biomarkers Prev·2008
8-other
Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?
PMID 17028980·Breast Cancer Res Treat·2007
8-other
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
PMID 16754727·JAMA·2006
4-observational
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
PMID 16288118·J Natl Cancer Inst·2005
2-rct
Quality of life and sexual functioning in cervical cancer survivors.
PMID 16234510·J Clin Oncol·2005
4-observational
Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma.
PMID 15712375·Cancer·2005
4-observational
Lysophosphatidic acid production and action: validated targets in cancer?
PMID 15258897·J Cell Biochem·2004
6-review
Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia.
PMID 12231524·Clin Cancer Res·2002
3-trial
Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide.
PMID 11045792·Cancer Epidemiol Biomarkers Prev·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1548365174
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 19
Are you this provider?
Claim Your Profile